Literature DB >> 32547120

Prevalence of Tuberculosis by Automated GeneXpert Rifampicin Assay and Associated Risk Factors Among Presumptive Pulmonary Tuberculosis Patients at Ataye District Hospital, North East Ethiopia.

Daniel Gebretsadik1, Nuru Ahmed2, Edosa Kebede1, Miftah Mohammed1, Melaku Ashagrie Belete1.   

Abstract

BACKGROUND: Tuberculosis is a communicable disease that is a major cause of ill health, one of the top 10 causes of death worldwide, and the leading cause of death from a single infectious agent, even ranking above human immuno-deficiency virus (HIV/AIDS).
OBJECTIVE: To assess the prevalence and associated risk factor of Mycobacterium tuberculosis among pulmonary tuberculosis (PTB) suspects attending at Ataye District Hospital from October 1, 2018, to February 30, 2019.
METHODOLOGY: A facility-based cross-sectional study was conducted among 423 presumptive tuberculosis patients at Ataye District Hospital. Sputum was processed by MTB/RIF Xpert assay. Data were entered into EpiData 3.1 software and exported to SPSS version 20.0 (SPSS, Chicago, IL, USA) for analysis. Univariate and multivariate analyses were used to examine the relationship between the dependent and independent variables. Variables that show significance at P-value of 0.3 during univariate analysis were selected for multivariable analysis. A P-value of less than or equal to 0.05 was used to indicate statistical significance.
RESULTS: Out of the total study participants, about 60% were male, and 39% were aged between 18 and 24 years. Of the total 423 PTB suspected patients, 38 (8.98%) of them were identified as having PTB by GeneXpert and 2/38 (5.3%) were resistant to rifampicin and 3/38 (7.89%) patients were co-infected with HIV. Participant age between 18 and 24 years and between 25 and 34 years, weight loss, chest pain, having contact history with confirmed PTB cases, utilization of congested transportation, and a history of imprisonment were significantly associated with the prevalence of PTB.
CONCLUSION: A considerable prevalence of PTB in the area was observed and the magnitude of MDR-TB was low. PTB is still a public health problem in Ethiopia and there is a need for collaborative prevention and control activities in the study area.
© 2020 Gebretsadik et al.

Entities:  

Keywords:  Ataye; Ethiopia; MTB/RIF Xpert assay; PTB

Year:  2020        PMID: 32547120      PMCID: PMC7247715          DOI: 10.2147/IDR.S248059

Source DB:  PubMed          Journal:  Infect Drug Resist        ISSN: 1178-6973            Impact factor:   4.003


  32 in total

1.  The additional yield of GeneXpert MTB/RIF test in the diagnosis of pulmonary tuberculosis among household contacts of smear positive TB cases.

Authors:  Dereje Habte; Muluken Melese; Nebiyu Hiruy; Zewdu Gashu; Degu Jerene; Feleke Moges; Sisay Yifru; Belaineh Girma; Yewulsew Kassie; Yared Kebede Haile; Pedro Guillermo Suarez; Belay Tessema
Journal:  Int J Infect Dis       Date:  2016-07-08       Impact factor: 3.623

Review 2.  Role of the clinical mycobacteriology laboratory in diagnosis and management of tuberculosis in low-prevalence settings.

Authors:  Nicole M Parrish; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2010-12-22       Impact factor: 5.948

3.  What causes smear-negative pulmonary tuberculosis in Malawi, an area of high HIV seroprevalence?

Authors:  N J Hargreaves; O Kadzakumanja; S Phiri; D S Nyangulu; F M Salaniponi; A D Harries; S B Squire
Journal:  Int J Tuberc Lung Dis       Date:  2001-02       Impact factor: 2.373

4.  Prevalence of tuberculosis, HIV, and TB-HIV co-infection among pulmonary tuberculosis suspects in a predominantly pastoralist area, northeast Ethiopia.

Authors:  Mulugeta Belay; Gunnar Bjune; Fekadu Abebe
Journal:  Glob Health Action       Date:  2015-12-18       Impact factor: 2.640

5.  Smear positive pulmonary tuberculosis and associated factors among homeless individuals in Dessie and Debre Birhan towns, Northeast Ethiopia.

Authors:  Tsedale Semunigus; Belay Tessema; Setegn Eshetie; Feleke Moges
Journal:  Ann Clin Microbiol Antimicrob       Date:  2016-08-31       Impact factor: 3.944

6.  Rifampicin-resistant Mycobacterium tuberculosis among tuberculosis-presumptive cases at University of Gondar Hospital, northwest Ethiopia.

Authors:  Kefyalew N Jaleta; Mucheye Gizachew; Baye Gelaw; Habtie Tesfa; Alem Getaneh; Belete Biadgo
Journal:  Infect Drug Resist       Date:  2017-06-14       Impact factor: 4.003

7.  Prevalence of rifampicin resistant Mycobacterium tuberculosis among presumptive tuberculosis patients in selected governmental hospitals in Addis Ababa, Ethiopia.

Authors:  Balew Arega; Fiqrte Menbere; Yitagesu Getachew
Journal:  BMC Infect Dis       Date:  2019-04-04       Impact factor: 3.090

8.  Evaluation of GeneXpert MTB/RIF system performances in the diagnosis of extrapulmonary tuberculosis.

Authors:  Youness Mechal; Elmostafa Benaissa; Nadia El Mrimar; Yassine Benlahlou; Fatna Bssaibis; Adil Zegmout; Mariama Chadli; Yashpal S Malik; Nadia Touil; Ahmed Abid; Adil Maleb; Mostafa Elouennass
Journal:  BMC Infect Dis       Date:  2019-12-19       Impact factor: 3.090

9.  Prevalence of Pulmonary Tuberculosis and Associated Factors Among HIV Positive Patients Attending Antiretroviral Therapy Clinic at Arba Minch General Hospital, Southern Ethiopia.

Authors:  Mohammedaman Mama; Aseer Manilal; Haile Tesfa; Hawa Mohammed; Endeshaw Erbo
Journal:  Open Microbiol J       Date:  2018-05-31

10.  Prevalence of rifampicin resistance by automated Genexpert rifampicin assay in patients with pulmonary tuberculosis in Yenagoa, Nigeria.

Authors:  Peter Ogie Ikuabe; Ikenna Desmond Ebuenyi
Journal:  Pan Afr Med J       Date:  2018-04-06
View more
  6 in total

1.  GeneXpert Based Confirmed Cases among Suspected Cases of Tuberculosis in a Tertiary Care Centre: A Descriptive Cross-sectional Study.

Authors:  Prabesh Pant; Kishor Gurung; Nitesh Shrestha; Subhechhya Basnet
Journal:  JNMA J Nepal Med Assoc       Date:  2022-03-11       Impact factor: 0.556

2.  Rifampicin-Resistant Mycobacterium tuberculosis Among Patients with Presumptive Tuberculosis in Addis Ababa, Ethiopia.

Authors:  Shambel Araya; Abebe Edao Negesso; Zemenu Tamir
Journal:  Infect Drug Resist       Date:  2020-10-06       Impact factor: 4.003

3.  Magnitude and Associated Factors of Pulmonary Tuberculosis Among HIV/AIDS Patients Attending Antiretroviral Therapy Clinic at Debre Tabor Specialized Hospital, Northwest Ethiopia, 2019.

Authors:  Teklehaimanot Kiros; Eninur Dejen; Mulu Tiruneh; Tegenaw Tiruneh; Tahir Eyayu; Shewaneh Damtie; Kefyalew Amogne
Journal:  HIV AIDS (Auckl)       Date:  2020-12-03

4.  Magnitude of Mycobacterium tuberculosis Infection and Its Resistance to Rifampicin Using Xpert-MTB/RIF Assay Among Presumptive Tuberculosis Patients at Motta General Hospital, Northwest Ethiopia.

Authors:  Tesfaye Andualem Demissie; Dereje Belayneh
Journal:  Infect Drug Resist       Date:  2021-04-07       Impact factor: 4.003

5.  Bridging the Gap in End Tuberculosis Targets in the Elderly Population in Eastern China: Observational Study From 2015 to 2020.

Authors:  Kui Liu; Zhenhua Xie; Gaofeng Cai; Bin Chen; Bo Xie; Songhua Chen; Yu Zhang; Wei Wang; Qian Wu
Journal:  JMIR Public Health Surveill       Date:  2022-07-29

6.  Detection of Mycobacterium tuberculosis and rifampicin resistance by Xpert® MTB/RIF assay among presumptive tuberculosis patients in Addis Ababa, Ethiopia from 2014 to 2021.

Authors:  Getu Diriba; Ayinalem Alemu; Habteyes Hailu Tola; Kirubel Eshetu; Bazezew Yenew; Misikir Amare; Biniyam Dagne; Hilina Mollalign; Waganeh Sinshaw; Yeshiwork Abebaw; Getachew Seid; Mengistu Tadesse; Betselot Zerihun; Melak Getu; Shewki Moga; Abyot Meaza; Dinka Fekadu Gamtesa; Zigba Tefera; Amanuel Wondimu; Michael Hailu; Bedo Buta; Muluwork Getahun; Abebaw Kebede
Journal:  IJID Reg       Date:  2022-09-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.